The Guardian - Pharmaceutical Industry

MARCH 10, 2024

The latest award brings to £137m the amount he has earned since joining in 2012. a year earlier. While it drew the anger of corporate governance experts, Soriot’s generous payout was just a fraction of the sums his counterparts at the biggest US companies take home.

Packaging 128

Packaging 128

STAT

NOVEMBER 7, 2023

The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequately tested and treated. Read the rest…

145

145

Drug Topics

APRIL 5, 2023

Data suggest confirmatory trials conducted for drugs granted accelerated approval by the FDA have taken over 3 years on average to complete since 2012.

FDA 98

FDA 98

STAT

OCTOBER 20, 2023

He saw his brother excel at what he did, but Pratt’s life changed in 2012 when his brother was shot and killed in Chicago’s South Side. Abdullah Pratt was only ever interested in science and in sports because of his older brother Rashad.

113

113

STAT

NOVEMBER 18, 2023

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. The revolution started in silence. It was called CRISPR-Cas9.

145

145

Pharmacy Times

AUGUST 17, 2022

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

122

122

The Guardian - Pharmaceutical Industry

FEBRUARY 20, 2024

Soriot, who has made nearly £120m in the decade since he took the helm at the drugmaker in October 2012 , was paid £16.9m last year, including salary, benefits and bonuses, up from £15.3m the year before, according to AstraZeneca’s annual report. Continue reading.

Packaging 77

Packaging 77

STAT

SEPTEMBER 18, 2023

more than doubled from 1991 and 2012 and has continued to grow steadily in the years since. The number of credentialed midwives — including both certified nurse-midwives, who can attend births in hospital settings, and a minority of certified midwives, who don’t hold a nursing degree — in the U.S.

Hospitals 145

Hospitals 145

STAT

JULY 18, 2023

But many immigrants don’t have access to this coverage, making them more vulnerable to maternal health problems, as highlighted by a new study of nearly 73,000 postpartum people across 19 states and New York City between 2012 and 2019. Read the rest…

98

98

Pharmacy Times

MAY 22, 2023

Blasini joined FCS in 2012 as a hematopathologist and has served as co-director of the Pathology Laboratory since 2018.

65

65

STAT

MAY 22, 2023

In 2012, the United States Preventive Services Task Force convened to determine whether it should recommend kidney disease screening for all Americans. Advocates had been pushing for it, citing ballooning rates of chronic kidney disease. But at the time, the group found there wasn’t enough evidence to say if screening was a net good.

106

106

Blog: Ask a Student Pharmacist

OCTOBER 4, 2023

Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

52

52

STAT

FEBRUARY 3, 2023

The drugs, a number of so-called modulators approved starting in 2012, have been one of the great biotech success stories. Continue to STAT+ to read the full story…

98

98

The Guardian - Pharmaceutical Industry

JANUARY 19, 2023

Hody Childress, a farmer and US air force veteran, began his anonymous charitable campaign when he walked into a drug store in his home town of Geraldine in 2012 and learned from the owner that sometimes families can’t afford to pay for their medicines. Continue reading.

99

99

STAT

MAY 9, 2023

In 2012, Ranbaxy paid a $350 million fine to U.S. As a result, the company has halted exports from the plant to the United States. At issue is a facility Sun bought eight years ago from Ranbaxy Laboratories, which was a poster child for lax manufacturing standards in India.

FDA 94

FDA 94

BioPharm

JANUARY 15, 2024

Since 2012, we’ve been the industry leader in custom mRNA synthesis for research and clinical applications. Want to increase the probability success for your discovery mRNA program? Partner with TriLink BioTechnologies®. Read on to see how TriLink® is determined to deliver you success.

40

40

STAT

MAY 4, 2023

Between 2012 and 2021, 14% of roughly 19,000 patent applications did not disclose financial support from the NIH or did not do so as required by federal law. And a new analysis finds a key reason may be most institutions and researchers that receive NIH support fail to fully or correctly disclose this information when applying for patents.

101

101

STAT

APRIL 1, 2024

Since taking the helm in 2012, Soriot has turned AstraZeneca into the second-largest company on the FTSE 100 index and last year received £16.9 … AstraZeneca’s plan to pay chief executive officer Pascal Soriot up to £18.7 and European peers.

101

101

STAT

OCTOBER 2, 2023

” That train of thought — calculating risks, eliminating threats — eventually led her to a job with the Food and Drug Administration in 2012 as a public health analyst. And I thought, doesn’t that mean nobody should really be sliding down poles?”

Insurance 120

Insurance FDA Hospitals 120

The Checkup by Singlecare

OCTOBER 20, 2023

Another 2012 article suggests that a formula containing shilajit and vitamin B complex may be effective against Alzheimer’s disease. In a 2012 animal study , researchers induced chronic fatigue syndrome (CFS) in rats for 21 days. Too much tau protein can trigger brain inflammation and brain tissue damage.

Immunization 105

Immunization FDA 105

STAT

AUGUST 15, 2023

One study found that, of nearly 40,000 patients who received a surgery to treat ischemic stroke from 2012 to 2017, close to half required inter-hospital transfer.

Hospitals 97

Hospitals 97

STAT

JUNE 28, 2023

He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012. But Unguru didn’t see this particular patient recently or even in the last year. Continue to STAT+ to read the full story…

Chemotherapy 102

Chemotherapy Hospitals 102

STAT

NOVEMBER 3, 2022

The original guidelines , issued in 2016, helped further drive down opioid prescribing levels that had been in decline since 2012, as the country grappled with its legacy of overprescribing that contributed to the overdose epidemic.

100

100

STAT

AUGUST 10, 2023

trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6

Insurance 92

Insurance Pharmaceutical Companies Pharmaceutical Companies 92

STAT

MAY 26, 2023

From 2012-2018, for example, Hispanic people comprised just 9% of participants in NIH-funded studies yet make up approximately 20% of the U.S. population. Continue to STAT+ to read the full story…

93

93

European Pharmaceutical Review

FEBRUARY 29, 2024

and Genmab A/S made an agreement in August 2012, in which Janssen would be granted an exclusive license to develop, manufacture and commercialise daratumumab. ” The Janssen Pharmaceutical Companies of Johnson & Johnson noted that Janssen Biotech, Inc.

Documentation 97

Documentation Pharmaceutical Companies Pharmaceutical Companies 97

The Guardian - Pharmaceutical Industry

JULY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) said it had taken “immediate” action under regulation 28 of the Human Medicines Regulations 2012 law “where it appears to the MHRA that in the interests of safety the licence should be suspended”. Continue reading.

Chemotherapy 50

Chemotherapy 50

Pharma Marketing Network

JULY 17, 2023

Anna was named a Top 100 PharmaVoice “most inspiring leader” in 2012. With Anna at the helm, MedEvoke has quickly become a leading partner to many top-20 pharmaceutical corporations.

52

52

The People's Pharmacy

MARCH 27, 2023

Research over the past decade suggests that coffee drinkers are less likely to be diagnosed with heart failure ( Circulation: Heart Failure , online June 26, 2012) or develop type 2 diabetes ( American Journal of Clinical Nutrition , April, 2010).

Compounding 63

Compounding 63

European Pharmaceutical Review

APRIL 27, 2023

AAVs evolving the in vivo gene therapy space In 2012, the European Medicines Agency (EMA) approved the first AAV gene therapy, Glybera (Alipogene tiparvovec). Achieving this in the relatively new and dynamic CGT regulatory landscape will rely on flexible and agile developers and manufacturers.

84

84

European Pharmaceutical Review

FEBRUARY 27, 2024

In 2012, Dame June was elected as the first chair of the European Pharmacovigilance Risk Assessment Committee, MHRA added. Her educational background includes training in medicine in Oxford after completing a master’s degree by research in Pharmacology.

Communication 92

Communication Vaccines 92

pharmaphorum

JULY 22, 2022

The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to balloon from around £2 million a year in 2012 to £50 million the following year.

110

110

pharmaphorum

NOVEMBER 11, 2022

Black/African American participation in trials has been declining over the past decade, says the report, falling from around 12% in 2012 to less than 10% in 2019 and 2020. For Hispanics, participation in trials increased from 7% in 2012 to a high of just under 10% in 2017 but fell back to levels of around 8% to 9% in the past two years.

FDA 86

FDA 86

European Pharmaceutical Review

DECEMBER 14, 2023

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 Lane S, Lynn E, Shakir S.

Medical Records 111

Medical Records Vaccines Hospitals 111

pharmaphorum

JANUARY 3, 2023

In an illustrious career, he also served as president of the Royal Society of Medicine (RSM) from 2012 to 2014, as well as chairman of the Committee on Safety of Medicines (1992-1998), chairman of the Advisory Council on the Misuse of Drugs (1998-2008), and chairman of UK Biobank (2012-2019), and was also appointed honorary professor at the London (..)

52

52

The Guardian - Pharmaceutical Industry

DECEMBER 5, 2023

Its groundbreaking Kalydeco drug was licensed in Europe in 2012 and useful at first to only a small percentage of sufferers. And they have been plunged to the depths when those new drugs have been denied them because of their cost. The drugs that have caused such a stir are made by the US biotech company Vertex.

Labelling 54

Labelling 54

European Pharmaceutical Review

NOVEMBER 22, 2023

Since most patients have an initial response to the treatment, 80 percent will experience recurrence and require subsequent therapies, according to a 2012 paper published in Annals of Oncology.

Chemotherapy 80

Chemotherapy Labelling 80